A
Annexon Biosciences
Brisbane, United States
Founded 2011 NASDAQ: ANNX
Nanomedicine Nano-Bio Protein Nanoparticles Nanobiomarkers Regenerative Medicine Gene Therapy Delivery
About
Complement cascade inhibitors for neurological diseases
Company Details
- Type
- public
- Employees
- 100+
- Funding
- Public
Key Products
- ANX005
- Complement Therapy